BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10578134)

  • 1. Non-adrenergic binding of [3H]atipamezole in rat kidney--regional distribution and comparison to alpha2-adrenoceptors.
    Sjöholm B; Lähdesmäki J; Pyykkö K; Hillilä M; Scheinin M
    Br J Pharmacol; 1999 Nov; 128(6):1215-22. PubMed ID: 10578134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of [3H]atipamezole as a radioligand for alpha 2-adrenoceptors.
    Sjöholm B; Voutilainen R; Luomala K; Savola JM; Scheinin M
    Eur J Pharmacol; 1992 Apr; 215(1):109-17. PubMed ID: 1355439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]2-(2-Benzofuranyl)-2-imidazoline, a highly selective radioligand for I2-imidazoline receptor binding sites. Studies in rabbit kidney membranes.
    Hosseini AR; King PR; Louis WJ; Gundlach AL
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):131-8. PubMed ID: 9007853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of binding sites for [3H]-idazoxan, [3H]-P-aminoclonidine and [3H]-rauwolscine in the kidney of the dog.
    Evans RG; Haynes JM
    Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):649-58. PubMed ID: 7813124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
    Wright IK; Blaylock NA; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of the alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on brain alpha 2-adrenoceptors and I2-imidazoline sites in vitro and in vivo.
    Miralles A; Ribas C; Olmos G; García-Sevilla JA
    J Neurochem; 1993 Nov; 61(5):1602-10. PubMed ID: 8228980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain.
    Mallard NJ; Hudson AL; Nutt DJ
    Br J Pharmacol; 1992 Aug; 106(4):1019-27. PubMed ID: 1356565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidazoline receptors, non-adrenergic idazoxan binding sites and alpha 2-adrenoceptors in the human central nervous system.
    De Vos H; Bricca G; De Keyser J; De Backer JP; Bousquet P; Vauquelin G
    Neuroscience; 1994 Apr; 59(3):589-98. PubMed ID: 8008210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.
    Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ethyl-3H]RS-79948-197 alpha2-adrenoceptor autoradiography validation in alpha2-adrenoceptor knockout mice.
    Fagerholm V; Philipp M; Hein L; Scheinin M
    Eur J Pharmacol; 2004 Aug; 497(3):301-9. PubMed ID: 15336948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does [3H]2-methoxy-idazoxan (RX 821002) detect more alpha-2-adrenoceptor agonist high-affinity sites than [3H]rauwolscine? A comparison of nine tissues and cell lines.
    Erdbrügger W; Raulf M; Otto T; Michel MC
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1287-94. PubMed ID: 7791100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]p-aminoclonidine and [3H]idazoxan label different populations of imidazoline sites on rat kidney.
    MacKinnon AC; Stewart M; Olverman HJ; Spedding M; Brown CM
    Eur J Pharmacol; 1993 Feb; 232(1):79-87. PubMed ID: 8096190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]cirazoline as a tool for the characterization of imidazoline sites.
    Angel I; Le Rouzic M; Pimoule C; Graham D; Arbilla S
    Ann N Y Acad Sci; 1995 Jul; 763():112-24. PubMed ID: 7677320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the binding activities of some drugs on alpha 2A, alpha 2B and alpha 2C-adrenoceptors and non-adrenergic imidazoline sites in the guinea pig.
    Uhlén S; Muceniece R; Rangel N; Tiger G; Wikberg JE
    Pharmacol Toxicol; 1995 Jun; 76(6):353-64. PubMed ID: 7479575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to alpha 2-adrenoceptors in rat cerebral cortical membranes.
    Wallace DR; Muskardin DT; Zahniser NR
    Eur J Pharmacol; 1994 Jun; 258(1-2):67-76. PubMed ID: 7925601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modulation of alpha2-adrenoceptor subtypes in rat kidney by chronic desipramine treatment.
    Callado LF; Gabilondo AM; Meana JJ
    Life Sci; 1999; 64(25):2327-39. PubMed ID: 10374896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
    Renouard A; Widdowson PS; Cordi A
    Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes.
    Alemany R; Olmos G; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]RS79948-197 binding to human, rat, guinea pig and pig alpha2A-, alpha2B- and alpha2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine.
    Uhlén S; Dambrova M; Näsman J; Schiöth HB; Gu Y; Wikberg-Matsson A; Wikberg JE
    Eur J Pharmacol; 1998 Feb; 343(1):93-101. PubMed ID: 9551719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.